GlassScriptPhysician profile
Eric Michael Padegimas
NPI 1992148761
$9,967.78
in general payments reported to CMS, 2019-2025
13 companies · $839 in 2025
The $839 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,847 · 2020: $104 · 2021: $2,542 · 2022: $172 · 2024: $464 · 2025: $839.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935 · Travel and Lodging: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $935.14 |
| Travel and Lodging | $367.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $3,691.85 | 2019-2025 | Djo Surgical |
| Gotham Surgical Solutions & Devices, INC. | $2,400.00 | 2021 | |
| Liberty Surgical INC. | $1,691.00 | 2019 | |
| Arthrex, INC. | $746.97 | 2019 | |
| Restor3d, INC. | $678.13 | 2025 | |
| Smith+Nephew, INC. | $165.55 | 2019-2021 | |
| Davol INC. | $158.61 | 2022 | |
| Horizon Therapeutics Plc | $144.87 | 2019-2022 | |
| Stryker Corporation | $91.62 | 2019 | |
| Carbofix Orthopedics INC | $64.64 | 2019 | |
| Depuy Synthes Sales INC. | $58.44 | 2019-2024 | Orthovisc, Peak |
| Integra Lifesciences Corporation | $47.34 | 2019 | |
| Polaris Technology Solutions LLC | $28.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Padegimas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.